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Abstract
Background: Shuanglong formula (SLF), a Chinese medicine composed of panax ginseng and salvia miltiorrhiza
exhibited significant effect in the treatment of myocardial infarction (MI) in clinical. Because of the complex nature
and lack of stringent quality control, it’s difficult to explain the action mechanism of SLF.
Method: In this study, we present a “system to system” (S2S) mode. Based on this mode, SLF was simplified
successively through bioactivity-guided screening to achieve an optimized minimal phytochemical composition
(new formula NSLF6) while maintaining its curative effect for MI.
Results: Pharmacological test combining with the study of systems biology show that NSLF6 has activity for
treatment MI through synergistic therapeutic efficacies between total ginsenosides and total salvianolic acids via
promoting cardiac cell regeneration and myocardial angiogenesis, antagonistic myocardial cell oxidative damage.
Conclusions: The present S2S mode may be an effective way for the discovery of new composite drugs from
traditional medicines.
Background
Dr. Zerhouni pointed out in NIH’s Roadmap that transla-
tional medicine may evoke a great evolution of medicine
in 21st century [1]. The conventional drug (western med-
icine) is screened based on single entity and its interac-
tion with single target, representing as ‘point to point’
(P2P) mode. However, its R&D productivity has experi-
enced decades of decline with the greatly increased cost
and lengthened time [2]. Some of those problems of sin-
gle-target-based screening may be overcome with the
proposal of systems biology which believe that the body
system is a holistic well-organized system composed of
ordered networks including genes, proteins, metabolites,
and so on. The network pharmacology based on the
development of systems biology may represent an inter-
action mode of single (or multiple) point and biological
system (point to system, P2S) [3]. Since Translational
Medicine emphasizes on exploring the synergy and inter-
action of various networks and combining knowledge
across disparate domains, interests are arouse if Transla-
tional Medicine will impact on Traditional Chinese Med-
icine (TCM) and catalyze the mixing of western medicine
and eastern medicine.
TCM has not been fully accepted by mainstream med-
icine whereas it has a long history of clinical practice in
China and beyond China. Besides of the complex nature
of the formulae, as well as a lack of stringent quality
control, the main obstacles of understand TCM may be
attributed to its holistic treatment concept representing
the interaction of drug system and human system which
is quite different with the “P2P” mode of western medi-
cine [4].
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formulas have being developed according to the routine
of “Beside-Bench-Beside” which is also similar with the
proposal of Translational Medicine. Many of the TCM
formulas have a proven efficacy in clinical application.
The pioneering work of Prof. Cheng’sg r o u pf r o mY a l e
University proved the efficacy of a TCM formula
(PHY906) and interpreted its mechanism by modern
pharmacological study [5], demonstrated the necessity
and rationality of TCM’s combination use to the inter-
national communities, and helped the communication of
Chinese traditional medicine and modern medicine.
In the past study we have introduced approaches of
Chemomics and systems biology to study the composi-
tion of a chemome (e.g. a TCM formula) and the corre-
lation between its change and biological effect [6,7].
Prof. Sutherland from Brunel University commented
that Chemomics represents an interesting synthesis of
both Eastern and Western culture and provide a new
“omics” approach to develop “modernized composite
medicine” (MCM), where “the phytochemical composi-
tion of a herbal formula with demonstrated clinical effi-
cacy is regarded as a global chemome, which can be
simplified successively through bioactivity-guided
screening to achieve an optimized chemomome with
minimal phytochemical composition for further drug
development, while maintaining its curative effect for a
specific disease” [8].
Here we present a mode of “system to system” (S2S)
by integrating Chemomics and systems biology which is
so called Integrative System Biology approach to study
the interaction of drug system and biological system
(Additional file 1: Figure S1). Different from conven-
tional lead compound screening based on the selected
target (P2P mode), the presented S2S methodology is
advantaged for TCM formula with proven clinical effi-
cacy, characterizing the chemical composition and their
relationship of the TCM drug system by means of Che-
momics, characterizing the response of the biological
system by means of Systems Biology, providing a com-
prehensive approach for understanding the interaction
of both systems. As a demonstrative study, the develop-
ment of a new drug (NSLF6) for therapy of myocardial
infarction (MI) from TCM shuanglong formula (SLF)
was presented here. The Chinese medicine SLF, a com-
bination of panax ginseng (PG) and salvia miltiorrhiza
(SM) at a ratio of 7:3, has been used for the clinical
treatment of cardiovascular diseases such as myocardial
infarction (MI) and angina pectoris over ten years by
Professor Lianda Li, Xiyuan Hospital of China Academy
of Chinese Medical Sciences. Former studies based on
MI models of rats, pigs, and dogs showed that SLF
alone or combined with mesenchymal cell transplanta-
tion could reduce myocardial infarct area and the degree
of myocardial injuries, improve cardiovascular function,
and increase myocardial blood and myocardial capillary
density [9-11]. Nevertheless, as similar as the most tradi-
tional medicines, the poorness and difficulty in quality
control and pharmacological interpretation was one of
the bottlenecks for further development of new drugs.
Therefore, it is necessary to simplify it successively
through bioactivity-guided screening to achieve an opti-
mized minimal phytochemical composition and interpret
its action mechanism clearer. The roadmap of the study
is shown in Figure 1.
Methods
Panax ginseng, Salvia miltiorrhiza, SLF and NSLF were
provided by Guangzhou Xiangxue Pharmaceutical Co.,
Ltd. The detailed descriptions for the studies of global
chemome fingerprint and quantitative fingerprint analy-
sis together with serum pharmacochemistry were given
in the Supplementary Material.
Methods of MI rat models
The animal experiments were operated in accordance
with the standards established by the Guide for the Care
and Use of Laboratory Animals of Beijing city and
approved by the local ethics committee (IACUC#: 2010-
LuoGA-SMI). Methods of isoproterenol (ISO)-induced
MI rat model and coronary artery ligation-induced MI
rat model were the same as before [12,13].
Metabolomic study methods
Method parameters of Metabolomic study of ISO-
i n d u c e dM Ir a ts e r u ma n dc o ronary artery ligation-
induced MI rat urine were the same as before [12,13].
Cell culture
Human Umbilical Vein Endothelial Cells (HUVECs)
were routinely cultured in Medium RPMI1640 supple-
mented with 10% fetal bovine serum (FBS), 100 μg/ml
penicillin/streptomycin. These cells were cultured in 5%
CO2 at 37°C and the media were replaced at 2-day
intervals.
HUVECs proliferation assay
HUVECs were grown to 70% confluence in 96-well
plates and cultured with indicated concentration of GS,
TSA and NSLF6. Cell proliferation was both measured
using MTT assay and direct counting. Each experiment
was carried out with five replicates per treatment and
was independently repeated more than three times.
Migration assay
Effect of NSLF on HUVECs migration was studied using
BD Chambers with Polycarbonate filters (8.0 μmp o r e ) .
Suspended cells (5 × 10
4) were placed on the filter in
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indicated concentrations of NSLF. In the lower chamber
RPMI1640 supplemented with 5% FBS was added. After
incubated 3 h at 37°C, the filter was removed, and the
upper side of the filter containing the nonmigrated cells
was wiped and rinsed. The filters were fixed with 4%
paraformaldehyde and stained with 4’,6-diamidino-2-
phenylindole (DAPI). Migration was quantified by
counting cells. All groups were studied in triplicate.
cDNA microarray
The cDNA microarray hybridization was performed as
previously described [14].
Real-time PCR
Total RNA was extracted from the cardiac tissue using
TRIZOL reagent (Invitrogen) and further purified with
RNeasy affinity column (MN). First-strand cDNA was
synthesized using First strand cDNA synthesis Kit (Fer-
mentas). Primers of Arnt1, Nppa and GAPDH were
designed by primer 3.0 (the information of primers was
shown in Additional file 1: Table S1). Each sample was
measured in triplicate. Cycle threshold (Ct) value of
each sample was obtained and 2
-ΔΔCt. Relative quantifi-
cation was used to calculate the gene expression. Each
quantitative PCR was preformed twice.
Capillary-like structure formation
HUVECs (10
4 cells/well) were cultured on growth factor
reduced-Matrigel (BD Biosciences) coated 24 plates in
RPMI1640 0.1% BSA containing 10-40 μg/ml NSLF6 or
vehicle. When cultured on matrigel, cells assemble into
capillary-like structures. After incubated 18 h, the cord-
like structures were observed by an inverted microscope.
Results
Screening of effective components in SLF
We have reported a urine metabolomic study combined
with pharmacological tests based on coronary artery
ligation-induced MI rat model and concluded that SLF
Figure 1 Screening and discovery of NSLF6 based on “system to system” mode.
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efficacies on MI [10].
A serum metabolomic study combined with pharmaco-
logical tests based on ISO-induced MI rat model was also
conducted here to validate the efficacy and optimize the
ratio of herbal combination of SLF. As shown in Figure
2A, the metabolic state of model group was far away from
the normal control group, indicating the success of ische-
mia model. Both PG group (Figure 2B) and SM group
(Figure 2C) were separate with the model group but away
from the control group. Among the groups of control,
model, and different combinations of PG and SM (8:2, 7:3,
and 6:4), the group of 7:3 (as original ratio as SLF) and 8:2
were the nearest to the control group and obvious away
from the model group, as shown in Figure 2D-F. Com-
bined with pharmacological tests such as electrocardio-
gram (ECG) changes, activity of enzymes (CK, LDH, SOD,
and MDA), and myocardial infarction area (Additional file
1: Figure S2, Additional file 1: Table S2-S4), we can con-
clude that the combination-based treatment groups were
Figure 2 PCA scores plots of ISO-induced MI rat serum. The rats were administrated with test drugs for 7 days at the same doses of 5 g/
kg·w·d and twice injections of ISO on days 6 and 7 to induce MI model. The samples were collected on the day 7. Serum samples were
analyzed using UPLC/TOF-MS and the data were processed by PCA in the software SIMCA-P package. SLF 8:2, 7:3, and 6:4 represent the ratios of
PG to SM. Details of the experimental procedures are given in Materials and Methods.
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combination of PG and SM at a ratio of 7:3 and 8:2 exhib-
ited the best therapeutic efficacies on MI rats. Since there
is little significant difference between the groups of 7:3
and 8:2, the original combination namely 7:3 has been
recommended for further development considering its
stronger basis of the clinical practice.
The serum-chemical and chemomics research results
indicated that ginsenosides and salvianolic acids might
be the effective components of SLF for MI (Additional
file 1: Table S5). To further verify the above deduction,
the two herbs (PG and SM) in SLF were divided into
four parts: total ginsenosides (TGS), the remainder of
PG (RPG, mainly containing panaxan, TGS removed),
total salvianolic acids (TSA), and the remainder of SM
(RSM, mainly containing diterpenoid quinones, TSA
removed). After cross combinations (equal to the ratio
of 7:3 of PG to SM), their efficacies were evaluated
using an ISO-induced MI rat model. As shown in Figure
3, a significant reduction (P <0 . 0 5 )i nC K ,L D H ,a n d
NEFA levels was observed in rats treated with the TGS
+T S A ,T G S+T S A+R P G ,T G S+T S A+R S M ,a n d
TGS + TSA + RPG + RSM (the original constitution of
SLF) compared with the model group. There were not
statistically significant differences (P >0 . 0 5 )i nt h eT S A
+R P G+R S M ,T G S+R P G+R S M ,a n dR P G+R S M
groups compared with the model group. The activities
of TGS + TSA were almost the same as the TGS + TSA
+ RPG + RSM. Besides, the results were confirmed by
the ECG changes and metabolomic studies (Additional
file 1: Figure S3, Additional file 1: Table S6).
On the one hand, the combination TGS + TSA exhib-
ited equal pharmacological activities with the original
SLF and the removal of the rest parts (RPG, RSM) had
no significant effect on activities. On the other hand,
a b s e n c eo fe i t h e r / b o t ho fg i n senosides and salvianolic
acids led to losing of anti-ischemic efficacy. Therefore,
we took the components of ginsenosides and salvianolic
acids as the indispensable effective components and
equivalence contributed to the anti-MI efficacy of SLF.
As a result, we obtained a new prescription with simpli-
fied compositions and maintaining efficacy, combination
of TGS and TSA as the equal ratio of which present in
the original formula SLF, named as “NSLF6”.
Study on chemistry and activity confirmation of NSLF6
The global chromatographic fingerprint of the NSLF6
was established by UPLC/TOF-MS. A total of 20 com-
pounds in NSLF6 were separated and identified, among
of which there were 12 ginsenosides and 8 salvianolic
acids. The quantitative fingerprints of total ginsenosides
and total salvianolic acids were established by HPLC-
DAD. As shown in Additional file 1: Table S7 and Addi-
tional file 1: Figure S4, the total contents of quantitative
compounds such as ginsenosides Rb1,R g 1, Ro, salvianolic
acid B, and lithospermic acid accounted for 74.4% of
total solids. Thus, most of the constituents in NSLF6
have been identified and quantifiable so that we have
established a stringent quality control, which provided
the chemical basis for unveiling the pharmacological
mechanism. Additionally, the comparative study of com-
ponents in plasma of rats before and after administration
of NSLF6 as well as NSLF6 was conducted by UPLC/
TOF-MS. The results showed that 5 salvianolic acids
including salvianolic acid B, rosmarinic acid, propanoid
acid, salvianolic E, and lithospermic acid, and 7 ginseno-
sides concluding ginsenoside Rb1,R b 2, Re, Rd, Rf, M-Rb1,
and M-Rb1 from NSLF6 were detected in plasma.
The activities of NSLF6 were evaluated by metabolo-
mics and pharmacological tests using MI rats induced
by coronary artery ligation. As shown in Figure 4A, the
endogenous metabolites in the model group were
obviously different from that of the normal control
group, indicating the success of myocardial ischemia
model. After two weeks’ survival without medication
(Figure 4B), the trajectory of the model group was far
Figure 3 Comparison of LDH, CK, and NEFA activity in serum of ISO-induced MI rats administrated different combinations. TGS: total
ginsenosides, RPG: the remainder of PG (mainly containing panaxan, TGS removed), TSA: total salvianolic acids, RSM: the remainder of SM
(mainly containing diterpenoid quinones, TSA removed). *P < 0.05, **P < 0.01 vs model group. Positive control drug: compound danshen pills.
Details of the experimental procedures are given in Materials and Methods.
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excluded the suspicion of self-cure of the MI rats during
the experiment. As shown in Figure 4C, the metabolic
state of the NSLF6 group was far away from the posi-
tion of normal control on the first day after coronary
artery ligation while the trajectory direction gradually
moved to the normal control during two weeks’ medica-
tion, indicating the recovery of the disturbed metabo-
lism state by NSLF6. In Figure 4D, both the NSLF6 and
positive control groups moved to the normal control
group, and the NSLF6 group exhibited better perfor-
mance in the recovery of metabolism than the positive
control group. The results confirmed that the NSLF6
had a proven efficacy in coronary artery ligation induced
MI rats. In addition, the pharmacological results (Addi-
tional file 1: Table S8-S9, Additional file 1: Figure S5)
showed that the NSLF6 could reduce the serum enzyme
activity, diminish the area of myocardial infarction, and
increase the myocardial capillary density [15].
NSLF6 promotes Human Umbilical Vein Endothelial cells
(HUVECs) proliferation, migration and angiogenesis
NSLF6 could significantly reduce myocardial infarction
area, and one of the mechanisms might be related to
promote angiogenesis and antagonize cardiomyocytes
oxidative damage.
Among NSLF6, TSA and TGS, NSLF6 (20 μg/ml)
exhibited the best activity in promoting cells prolifera-
tion (Figure 5A-B). The determination of cell migration
showed that NSLF6, TSA and TGS significantly
enhanced the ability of cell migration (Figure 5C), and
NSLF6 was optimal with migration rate increased 500%.
To evaluate the simulative effect on angiogenesis, we
treated HUVECs with NSLF6 (10, 20 and 40 μg/ml) for
18 h and examined their ability to form tubular forma-
tion. 20 μg/ml NSLF6 exhibited maximum promotion of
tubule formation (Figure 5D). The results showed that
NSLF6 had the effect on promoting HUVECs prolifera-
tion, migration and angiogenesis.
Figure 4 PLS-DA scores plots of rat urine data. (A) Dynamic mean-centered PLS-DA score plot of rat urine data of model, sham surgery, and
control groups on day 1. (B) Dynamic mean-centered PLS-DA score plot of rat urine data of model, sham surgery, and control groups on day
14. (C) Dynamic mean-centered PLS-DA score plot of rat urine data of NSLF6 group on days 0, 1, 7, and 14. (D) Dynamic mean-centered PLS-DA
score plot of rat urine data of NSLF6 and positive control drug group on day 14. Positive control drug: diltiazem hydrochloride. Details of the
experimental procedures are given in Materials and Methods.
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The model of cardiomyocytes damaged by H2O2 was
used to study the protective effect of NSLF6 and its
effective ingredients. After cardiomyocytes were co-cul-
tured with these drugs for 48 h, 10% H2O2–PBS solu-
tion was added to the medium, cultured for 2 h,
thereafter high content screening (HCS) system was
used to analyze the health degree of cardiomyocytes
[16]. The results indicated that the mitochondrial mem-
brane potential of those cardiomyocytes treated with
NSLF6 and its effective ingredients was higher, the
membrane permeability was lower and the nuclear was
integrity, compared with the model. These results sug-
gested that NSLF6 had the effect of antagonizing the
damage of cardiomyocytes induced by H2O2 (Figure 6,
Additional file 1: Figure S6). TSA and one of its major
constituents, salvianolic acid B (SAB) could both signifi-
cantly improve the mitochondrial membrane potential
of the damaged cardiomyocytes (Figure 6A-B), TGS sig-
nificantly reduced the membrane permeability, and
NSLF6 had the optimized effect on the maintenance of
nuclear integrity (Additional file 1: Figure S6). There-
fore, all of NSLF6 and its effective ingredients could
recover the rat cardiomyocytes damaged by H2O2.I n
summary, combined the results from three tests of mito-
chondrial membrane potential, the membrane perme-
ability and the nuclear integrity, NSLF6 had the best
effects and the optimal concentration was 10
-4 mol/l. In
addition, the investigation on the model of cardiomyo-
cytes damaged by Hypoxia/Reoxygenation (H/R) also
confirmed that NSLF6 had the protective effect on
damaged cardiomyocytes, and such a pharmacological
action was mainly contributed by TGS (Additional file
1: Table S10).
Study of NSLF6 based on Systems biology
Taking the coronary artery ligation induced MI rats
model, using cDNA microarray, the myocardial gene
expression profile was determined to screen the differen-
tially expressed gene induced by administrating NSLF6.
As a result, 476 genes displayed significant difference (fil-
ter: the change ratio ≥ 2, n ≥ 4. Additional file 1: Figure
S7 showed the results of cluster analysis and PCR verifi-
cation). After administrated NSLF6, the expression of
most differentially expressed genes was closed to the
SHAM group. By further analysis of the differentially
expressed gene, the relational protein interaction network
was preliminarily obtained (Figure 7). The glucose trans-
porter 4(GLUT4/slc2a4) was in the center of interaction
network. It suggested that GLUT4 played a key role in
the process of NSLF6 administration. Glucose is the
main material for providing energy, and GLUT4 is the
carrier of glucose and play an important role in glucose
uptake. N-Begum et al [17] reported that increased
Figure 5 Effects of NSLF6 on HUVECs proliferation, migration, and angiogenesis. (A) & (B) Cells were incubated for 24 h with GS, TSA and
NSLF6. Cell proliferation was evaluated by MTT assay (A) and cell counting (B). (C) Cell migration was examined by transwell chambers with
polycarbonate filters (8.0 μm pore) after incubation for 3 h. (D) Cells were seeded onto matrigel in 24-well plates. After incubated with NSLF6 for
18 h, tube formation was recorded photographically (40×). Results are expressed as percentage of control.*P < 0.05 versus control. n = 5. Details
of the experimental procedures are given in Supplementary Materials.
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phosphorylation of GLUT4 to inhibit its intrinsic activity
for glucose transport. Moreover, gene functional analysis
found that the differentially expressed genes were mainly
related to the pathways about energy metabolism, ion
binding, MAPK, and VEGF. These results suggested that
NSLF6 might mainly regulate the internal ion concentra-
tion and energy metabolism to display the efficacy. In
addition, protein kinase B (Akt/PKB) also involved in
NSLF6 treatment. And the PI3K/Akt pathway had note-
worthy effect in the course of MI treatment [18,19].
Using the same MI model as above, 24 of 26 differen-
tial endogenous metabolites in urine were identified
using high resolution mass spectrometry, involved in
metabolic processes related to myocardial energy meta-
bolism (myocardial energy metabolism, the citric acid
cycle, and amino acid metabolism) (Additional file 1:
Table S11). Among them, the levels of glucaric acid, uri-
dine, D-Glucuronic acid 1-phosphate, deoxyadenosine
monophosphate, 6-Phosphogluconic acid, and ceramide
were observed significantly increased and the others
were significantly decreased in model group compared
with the normal control group. The observation of the
differential endogenous metabolites moved to nearly
normal levels in NSLF6 group indicated that NSLF6
may exert therapeutic efficacies on MI by regulating
these metabolomic networks. For the study on SLF, we
have indentified 17 potential biomarkers related to the
Figure 6 Effect of NSLF6 and its effective ingredients on the membrane permeability of cardiomyocytes by H2O2.( A )F l u o r e s c e n c e
expressions of membrane permeability of the damaged cardiomyocytes stimulated by NSLF6 and its effective ingredients. Green fluorescent
shows the membrane permeability, blue fluorescence shows nucleus stained by DAPI. (B) Comparison of NSLF6 and its effective ingredients to
the membrane permeability of cardiomyocytes by H2O2. Details of the experimental procedures are given in Supplementary Materials.
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Page 8 of 11effect of SLF [13], and we find that 13 of them are also
contributed to the effect of NSLF6 and exhibit the con-
sistent variation trend. Furthermore, the 14 differential
endogenous metabolites in serum obtained from MI rats
induced by ISO had the same trends as the urine meta-
bolites (Additional file 1: Table S12).
Furthermore, the differentially expressed genes and
proteins were screened through comparative genomics
and comparative proteomics during the differentiation
from BMMSCs into cardiomyocyte-like cells induced by
NSLF6. 180 differentially expressed genes were obtained,
in which 10 genes (fold change ≥ 10) were confirmed by
Real-Time PCR, and obtained the functional relationship
(Additional file 1: Figure S8). The differentially
expressed proteins were obtained between control group
and the differentiation group, and the relative signaling
pathway network was obtained (Additional file 1: Figure
S9). These results suggested that the MAPK, calcium
binding, Rho and Wnt pathways played important roles
during the BMMSCs differentiation [20]. And NSLF6-
induced differentiation was mainly attributed to the
MAPK (eEF-2, Actb and Nme2), calcium binding (S100
calcium binding protein) and the Rho (Vim) signaling
pathways (Additional file 1: Table S13) [21].
DiscussionTraditional Chinese Compound Medicine
(TCCM) is known as multi-component drug capable of
Figure 7 The protein interaction network related to the anti-MI effect of NSLF6. Yellow means the genes encoding the protein contained
the differentially expressed genes in this experiment. Details of the experimental procedures are given in Supplementary Materials.
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action at multiple pathological steps. But these actions
represent integral regulation other than the sum of indi-
vidual target. Therefore, chemomics-integrated systems
biology (integrative systems biology, ISB), a holistic
methodology, was developed for the study of interaction
between external intervention system (TCM) and biolo-
gical response system (human system) based on S2S
mode. The Traditional Chinese Formula is a compatible
combination of raw herbs, in which indispensable com-
ponents co-exist with ineffective components. For
further drug development, it is necessary to remove the
ineffective components while maintaining its curative
effect for a specific disease. Consequently, we developed
a S2S mode by which a complex formula can be simpli-
fied successively through bioactivity-guided screening to
achieve a minimal effective composition with definite
constituents and controllable quality, so that its
mechanism can also be interpreted. In the present
study, TGS and TSA were screened from SLF according
to the studies of chemomics, serum pharmacochemistry,
metabolomics and activity evaluation. NSLF6, the sim-
plified prescription with components combination of
TSA and TGS was obtained, and the systems study on
the action mechanism of NSLF6 was conducted.
According pharmacological studies based on the MI
rat model induced by ISO or the coronary artery liga-
tion, NSLF6 can treat MI via several mechanisms such
as promoting cardiomyocytes renewal, promoting angio-
genesis and antagonizing cardiomyocytes oxidative
damage.
It has been reported that there are stem cells existing in
the heart of adult [21]. Whether NSLF6 has the effect of
promoting the differentiation of stem cells into cardio-
myocytes to treat myocardial infarction? The in vivo
experiments showed that SLF with bone marrow mono-
nuclear cells (BMMCs) auto-transplanted into myocar-
dial infarction model in swines could significantly
improve the survival, differentiation and amplification of
the transplanted cells in myocardial tissue, generate a raft
of new cardiomyocytes and microvascular, and eventually
promote lesions recovery, compared with BMMCs group
[13]. The above in vitro study proved that SAB, the effec-
tive ingredient of NSLF6, effectively induced the differen-
tiation of mESCs into cardiomyocytes with physiological
beating frequency. Except Vc and retinoic acid, there has
been few drug reported to have the inducing effect on
ESC differentiating into cardiomyocytes. Thus, NSLF6
has a good potential and specific advantage in the treat-
ment of MI. The study of genomic and metabolomic
above displayed the NSLF6 activity of regulating energy
metabolism, transcription factors and oxide reductase
activity, which was reported to be involved in the differ-
entiation of mESCs into cardiomyocytes [22].
Partial angiogenesis and remodeling after MI is an
important part of Cardiac Tissue Repair. Therapeutic
angiogenesis is the clinical use of methods to enhance
or promote the development of collateral blood vessels
in ischemic tissue, and vividly described as “self-medica-
tion for heart bypass”. The study of genomic and meta-
bolomic above displayed the NSLF6 activity of
regulating the energy metabolism, ion binding, MAPK
and VEGF pathway which was reported to be the most
Specific and powerful regulators to promote angiogen-
e s i s[ 2 3 ] .T h e r e f o r e ,w ec o n s i d e r e dt h a tN S L F 6c o u l d
promote angiogenesis through adjusting VEGF pathway,
and confirmed the promoting angiogenesis of NSLF6 on
HUVECs in vitro. Ginsenoside Rg1, one of ingredients
in NSLF6, could stimulate the expression of VEGF to
enhance the angiogenesis in previous report [24].
The H2O2 oxidative damage model of myocardial cells
was widely used in the study of ischemia/reperfusion
injury and ischemic preconditioning. It presents as the
destruction of nuclear integrity and membrane perme-
ability, increased mitochondrial membrane potential,
oxygen free radicals, myocardial damage induced
increase of enzyme activity, cell apoptosis, calcium over-
load and so on [25]. The activities of MDA [26], SOD
[27] and LDH [28] were closely related to the myocar-
dial oxidative damage. The study of cardiomyocytes
model based on HCS system and MI rats model based
on pharmacological test suggested that NSLF6 could
effectively protect cardiomyocytes via several mechan-
isms that act simultaneously, such as decreasing lipid
peroxidation, improving the myocardial cell’ ability of
oxygen free radicals, and resisting apotosis.
Conclusion
Based on the integrative system biology mode, the tradi-
tional Chinese medicine SLF, as a clinical effective medi-
cine, was developed to a new formula–NSLF6 with
comparatively clear phytochemical composition, com-
paratively clear mechanism, and controllable quality.
The stringent quality control system has been estab-
lished using combination of fingerprint and multi-com-
ponent determination. NSLF6 was proved to be effective
on MI by pharmacological test (four levels of animal,
tissue, cell, and molecular) combining with the study of
gene, protein, and metabolite networks. The results
revealed that SLF produced efficacy against MI through
synergistic therapeutic efficacies between TGS and TSA.
The present S2S mode may be an effective way for the
discovery of new compound medicines.
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